Stress responsivity, addiction, and a functional variant of the human mu-opioid receptor gene

被引：35

作者：

Kreek, Mary Jeanne

LaForge, K. Steven

机构：

[1] Rockefeller Univ, Lab Biol Addict Dis, New York, NY 10021 USA

[2] Univ Helsinki, Finnish Genome Ctr, Helsinki, Finland

来源：

MOLECULAR INTERVENTIONS | 2007年 / 7卷 / 02期

关键词：

D O I：

10.1124/mi.7.2.7

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

[No abstract available]

引用

页码：74 / 78

页数：5

共 25 条

[1] Increased attributable risk related to a functional μ-opioid receptor gene polymorphism in association with alcohol dependence in central Sweden [J].

Bart, G ;

Kreek, MJ ;

Ott, J ;

LaForge, KS ;

Proudnikov, D ;

Pollak, L ;

Heilig, M .

NEUROPSYCHOPHARMACOLOGY, 2005, 30 (02) :417-422

[2] Altered levels of basal cortisol in healthy subjects with a 118G allele in exon 1 of the mu opioid receptor gene [J].

Bart, Gavin ;

LaForge, K. Steven ;

Borg, Lisa ;

Lilly, Charles ;

Ho, Ann ;

Kreek, Mary Jeanne .

NEUROPSYCHOPHARMACOLOGY, 2006, 31 (10) :2313-2317

[3]

Barton SS, 2004, J INT FOOD AGRIBUS M, V16, P9, DOI 10.1300/J047v16n02_02

[4] mu opioid receptor gene variants: lack of association with alcohol dependence [J].

Bergen, AW ;

Peterson, R ;

Kokoszka, J ;

Long, JC ;

Virkkunen, M ;

Linnoila, M ;

Goldman, D .

MOLECULAR PSYCHIATRY, 1997, 2 (06) :490-494

[5] Effect of the A118G polymorphism on binding affinity, potency and agonist-mediated endocytosis, desensitization, and resensitization of the human mu-opioid receptor [J].

Beyer, A ;

Koch, T ;

Schröder, H ;

Schulz, S ;

Höllt, V .

JOURNAL OF NEUROCHEMISTRY, 2004, 89 (03) :553-560

[6] Single-nucleotide polymorphism in the human mu opioid receptor gene alters β-endorphin binding and activity:: Possible implications for opiate addiction [J].

Bond, C ;

LaForge, KS ;

Tian, MT ;

Melia, D ;

Zhang, SW ;

Borg, L ;

Gong, JH ;

Schluger, J ;

Strong, JA ;

Leal, SM ;

Tischfield, JA ;

Kreek, MJ ;

Yu, L .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (16) :9608-9613

[7] The mu-opioid receptor polymorphism A118G predicts cortisol responses to naloxone and stress [J].

Chong, RY ;

Oswald, L ;

Yang, XJ ;

Uhart, M ;

Lin, PI ;

Wand, GS .

NEUROPSYCHOPHARMACOLOGY, 2006, 31 (01) :204-211

[8] TREATMENT OF OPIOID-INDUCED CONSTIPATION WITH ORAL NALOXONE - A PILOT-STUDY [J].

CULPEPPERMORGAN, JA ;

INTURRISI, CE ;

PORTENOY, RK ;

FOLEY, K ;

HOUDE, RW ;

MARSH, F ;

KREEK, MJ .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 52 (01) :90-95

[9] Association between the cortisol response to opioid blockade and the Asn40Asp polymorphism at the μ-opioid receptor locus (OPRM1) [J].

Hernandez-Avila, CA ;

Wand, G ;

Luo, XG ;

Gelernter, J ;

Kranzler, HR .

AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2003, 118B (01) :60-65

[10] Hypothalamic-pituitary-adrenocorticaI (HPA) axis response and biotransformation of oral naltrexone: Preliminary examination of relationship to family history of alcoholism [J].

King, AC ;

Schluger, J ;

Gunduz, M ;

Borg, L ;

Perret, G ;

Ho, A ;

Kreek, MJ .

NEUROPSYCHOPHARMACOLOGY, 2002, 26 (06) :778-788

← 1 2 3 →